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Abstract. We investigated the effect of insulin on reactive oxygen species (ROS) production 
by human neutrophils stimulated with opsonized zymosan and incubated for 30 minutes with 
different insulin concentrations. For measuring ROS production, we used luminol-dependent 
chemiluminescence assay (CLLD). We observed that the CLLD depends on insulin concentration 
and this supports the hypothesis that insulin may play a role in ROS production by normal human 
neutrophils. 
Key words: human neutrophils, reactive oxygen species, chemiluminescence, insulin, luminol. 
INTRODUCTION  
Neutrophils play an important role in a variety of physiological and 
pathological processes, such as host defense, rheumatoid arthritis or post-ischemic 
reperfusion damages. During phagocytosis of microbial intruders, neutrophils 
increase their oxygen consumption (the “respiratory burst”) by the activity of an 
NADPH-oxidase that generates superoxide anion (O2–) and hydrogen peroxide 
(H2O2) [3, 5]. The importance of the respiratory burst became obvious when the 
chronic granulomatous disease syndrome, characterized by predisposition to 
bacterial and fungal infections, was shown to be associated with decreased oxygen 
consumptions as well as defective microbial killing [4, 7]. To date, the dormant 
oxidase has been shown to consist of one membrane bound and four cytosolic 
components. Upon cell activation, the cytosolic components translocate to the 
membrane bound component and a functional multi-component electron-transfer 
system is formed, that catalyzes the reduction of molecular oxygen at the expense 
of NADPH. The primary products (superoxide anion and hydrogen peroxide) 
generated by NADPH-oxidase are not reactive enough to account for the 
bactericidal effects; however, these oxygen species give rise to yet other reactive 
oxygen species (hydroxyl radicals, singlet oxygen, hypochlorous acid, and, 
probably, reactive nitrogen species) that are strongly anti-microbial [6]. 
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The neutrophil respiratory burst can be activated by a number of different 
soluble and particulate stimuli, including chemoattractants, certain cytokines, 
phorbol esters, calcium ionophores, different lectins, opsonized as well as various 
unopsonized microorganisms, drugs, and physical factors [9, 10, 11, 13]. 
Previous studies [12] showed that the effect of insulin on respiratory burst of 
mouse neutrophils activated by formyl-methionyl-leucyl-phenyladenine (fMLP) 
depends on temperature, duration of pretreatment of the neutrophils with insulin 
and the concentration of combination of insulin and fMLP. 
Our aim was to investigate if insulin may influence the respiratory burst of 
normal human neutrophils activated by opsonized zymosan, at room temperature. 
MATERIALS AND METHODS 
NEUTROPHIL PREPARATION 
To study their specific function in comparison with other types of 
leukocytes, it is desirable to isolate the PMNL from the whole blood. There are 
some available techniques for neutrophil isolation [5, 14]. We used a conventional 
isolation technique based on density differences between the cell populations, as 
follows. 
10 ml blood samples, obtained from healthy adult volunteers, were collected 
into 15 ml Falcon tubes, each containing 1 ml 1.5% Na2EDTA in phosphate 
buffered saline (PBS). PMNLs were separated from whole blood by continuous 
Percoll gradient centrifugation. This is a fast, one step method that avoids 
hypotonic lysis of erythrocytes and dextran sedimentation, which may activate 
neutrophils. The final neutrophil suspension in HBSS (Hank’s Balanced Salt 
Solution without Ca2+ and Mg2+) has 1.8⋅106 PMNLs per milliliter. 
ZYMOSAN PREPARATION 
A solution of 50 mg/ml zymosan A (Sigma) in PBS was prepared and kept as 
stock solution at 4 oC. Daily 1 part of zymosan stock solution was suspended in 9 
parts of fresh human serum and rotated slowly for 15 minutes at 37 °C for 
opsonization. Then the vial was span for 10 minutes at 2000 rpm and the pellet 
resuspended in HBSS to 1.25 mg/ml. 
LUMINOL PREPARATION 
A stock solution of 5.5 mM luminol (Sigma, MW 177.16) in DMSO 
(dimethylsulfoxide, Sigma) was prepared and kept at room temperature, in the 
dark. Daily a part of stock solution was diluted 1:50 in PBS. 0.2 ml of diluted 
solution were added per vial, resulting a final concentration of 4µM. 




Several chemiluminescent dyes that are activated by reactive oxygen species 
have been developed. Among these dyes, luminol (5 amino-2,3-dihydro-1,4 
phthalazindione) is the most frequently used in the free radical research field. 
Luminol is an activity amplifier with a high quantum yield, so that the 
chemiluminescence assay is very sensitive [2]. The luminol excitation reaction 
may take place extracellularly and intracellularly. In order that luminol should 
react with oxidants in the intracellular compartment, it has to cross biological 
membranes, but very little is known about the diffusion properties of the luminol 
molecule [5]. 
For measuring luminol-dependent chemiluminescence of human neutrophils, 
we used a TD20/20 Turner Design luminometer. Light emission 
(chemiluminescence), expressed as cpm, was measured for 70 minutes.  
To each scintillation vial we added 700 µL HBSS, 36 µL luminol solution (in 
order to obtain a final concentration of 4 µM), 72 µL opsonized zymosan, and 185 
µL PMNLs suspension. Previous aliquots from neutrophil suspension (1.8⋅106 
PMNLs per milliliter) were incubated for 30 minutes, at room temperature, with 
insulin (ActaRapid Novartis). The insulin concentrations in the final probes were 
3, 6, 11, 22, and 44 µU/ml, respectively. 
RESULTS 
Neutrophils were isolated from human venous blood obtained from 10 
normal adult donors (6 women and 4 males). 
Two control probes were prepared in each experiment: one contains 
nonstimulated neutrophils (no opsonized zymosan), and the other one, neutrophils 
and opsonized zymosan (to induce cell activation), both without insulin. The 
enhancement of chemiluminescent response of stimulated neutrophils in 
comparison with nonstimulated neutrophils is a measure of ROS production during 
the respiratory burst. 
In order to study the insulin effect, the probes were incubated with insulin at 
different concentrations and then activated with opsonized zymosan. 
We registered the chemiluminescence kinetics of nonactivated and opsonized 
zymosan activated PMNLs, at different insulin concentrations (Fig. 1). Each spot 
of the curves is an average of the values for the 10 normal adult donors. 
CLLD depends on insulin concentration. At 22 µU/ml insulin, CLLD values 
are very close to those of stimulated control probe (opsonized zymosan stimulated 
neutrophils without insulin). When neutrophils were incubated with the other 
insulin concentrations (6, 11 and 44 µU/ml), the CLLD values are lower. For a 
lower insulin concentration than the physiological ones (6 – 26 µU/ml [8]), 
respectively 3 µU/ml, the CLLD values are very close to those of nonstimulated 
control probe (nonactivated neutrophils without insulin).  
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Fig. 1. – Chemiluminescence kinetics of nonactivated and opsonized zymosan activated  
PMNLs, at different insulin concentrations: 3, 6, 11, 22 and 44 µU/ml, respectively. 
In all situations, the maximum chemiluminescent emission appears after 
about 20 minutes. 
DISCUSSION AND CONCLUSIONS 
We investigated the effect of insulin concentration on ROS production by 
human neutrophils using luminol-dependent chemiluminescence assay. For all 
insulin concentrations, the CLLD values are lower than or equal to those of 
stimulated control probe (neutrophils with opsonized zymosan but no insulin). At 
22 µU/ml insulin, the CLLD values are very close to that of stimulated control 
probe. So, we may assume that insulin inhibits ROS production. For a lower 
insulin concentration than the physiological ones, the CLLD values are very close 
to those of nonstimulated control probe (neutrophils without opsonized zymosan 
and insulin). That means that in this case the ROS production is strongly repressed. 
The CLLD variation upon insulin concentration supports the hypothesis that 
insulin may play a role in ROS production by normal human neutrophils, but the 
mechanism is not clear. 
Insulin effects at cellular level are mediated by insulin receptors. To date, 
insulin receptors from erythrocyte membrane are well identified [1], but very little 
is known about insulin receptors from neutrophil membrane. Further investigations 
are necessary to characterize the insulin receptors in human neutrophil membrane 
and its correlation with the NADPH-oxidase activity. 
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